GB stock · Healthcare sector · Drug Manufacturers—General
Company Logo

GSK plc

GSKNYSE

28.66

USD
-0.16
(-0.56%)
After Hours Market
12.34P/E
8Forward P/E
0.59P/E to S&P500
57.907BMarket CAP
2.99%Div Yield
Google Trends
Recent Reddit Comments

What's there to know? People like drugs.

But seriously all I meant was that while GSK is super low right now, the majority of that loss is due to the split with HLN.

1
Reply
Share
Report
Save
Follow

I think GSK is a little more complicated. They had a demerger from HLN that dropped like a quarter of it's price 2 months ago

1
Reply
Share
Report
Save
Follow

GSK hit it's 1996 prices today...if that's considered big.

1
Reply
Share
Report
Save
Follow

Wow, GSK back to its 1996 prices.....yikes.

1
Reply
Share
Report
Save
Follow

I am long GSK

1
Reply
Share
Report
Save
Follow

If anyone of you guys is looking for a swing trade, I'd recommend GSK or VOD. I see a great setup (especially) on GSK using the MACD and the RSI. I'm currently long VOD.

1
Reply
Share
Report
Save
Follow

Great entry point prices for these right now: NEGG, GSK, MCY, TWLO

1
Reply
Share
Report
Save
Follow

Long META, GSK, MCY, 1-800 Flowers. Calls on BABA. Puts on AAPL. Short HRB.

1
Reply
Share
Report
Save
Follow

Love GSK but idk if British companies are where I want to be at right now

1
Reply
Share
Report
Save
Follow

Long NEGG, BABA, TWLO, GSK, 1-800 Flowers

1
Reply
Share
Report
Save
Follow

Pfizer, Novartis, BMS, GSK, astra zenica, jnj, Merck, Gilead, Roche, maybe CSL Behring, maybe Beringer ingelheim, maybe German Merck (msd). These are the companies that spend >10B on RnD.

1
Reply
Share
Report
Save
Follow

ATM health, pfe, Sanofi(sny?), gsk and abbv. But can't go wrong with the giants appl msft goog amzn

1
Reply
Share
Report
Save
Follow

Nope you won't loose, you will still have 1000$ of stock but will get it in 2 companies after the split. This happened with HP when they split.

You can check, HP, GSK and see what happened historically to the stock prices. One interesting observation from me is that generally when companies split, weaker part does better in terms of value gain.

I have JnJ stocks in my portfolio and they will split in the end of the year and I'm very optimistic for the consumer company vs pharma.

1
Reply
Share
Report
Save
Follow

Put that $2k in GSK stock with a 7% divvy reinvesting automatically, pretend it’s gone and then come back in 20 years. You’ll be very very happy with your decision.

1
Reply
Share
Report
Save
Follow

Very similar philosophy but need the options income, kids still on the payroll. Had some unfortunate assignments but in balance been able to Roll out of situations not to my liking. What other stocks are you holding that you believe are good value for the long run and have high sustainable dividends? I'm heavily in pharma with ABBV, GILD, GSK, PFE plus some interesting Energy (SHEL, VLO, MLPX) and some small cap (TRTN, APAM) finally basic Financials (BNS, C).

1
Reply
Share
Report
Save
Follow

I am putting into GSK, good dividend and stock are 52 weeks low

1
Reply
Share
Report
Save
Follow

Long GSK, MCY, BABA, TWLO

0
Reply
Share
Report
Save
Follow

GSK plc GlaxoSmithKline? - the British multinational pharmaceutical and biotechnology company that produces Valtrex, used to treat genital herpes

1
Reply
Share
Report
Save
Follow

My personal opinion on $CYDY status based on research. I say it's speculation but see what you think.

Based on the "10 signs your company is getting bought out" One of the Signs is management does nothing to increase share price. That's because they already know a price range/ target has been reached daily share price does not matter.

Another sign is management goes quiet and provides only sec required communication to investors. Another sign is management starts removing people and open positions and board seats are not filled unless they have extensive M&A experience.

I think Cydy is getting acquired. Or at least one indication is. Partnerships with a company that only has one drug makes things muddled. Same drug with different partners for different indications would be very muddled due the off label, different time frames for approvals. CYDY is 772m in debt! The 350m shares even at 2 bucks won't cover the debt. But it does allow for a go it alone threat if not offered the price asked for. Also most 90%normal acquisitions/buyouts happen to non revenue and non approved drugs. Most small biotechs can't afford to run meaningful trials.

Looking at new members joining CYDY, Attorney company counsel Tyler Blok, President not CEO til after a 6 months trial Cyrus and Cunningham, board member Burke all new to Cydy all have extensive major M&A experience actually their specialty. And as usual my saying us being bought out is my opinion and speculation. And as I have all along maintained it will be ViiV and GSK with a possible outside chance buy out from Abbvie.

So my time line is only a guess. My thought is the buyout may happen before the added shares vote as if after the vote that just costs the acquiring company much more money to cover the shares.

1
Reply
Share
Report
Save
Follow

My personal opinion on CYDY status based on research. I say it's speculation but see what you think.

Based on the "10 signs your company is getting bought out" One of the Signs is management does nothing to increase share price. That's because they already know a price range/ target has been reached daily share price does not matter.

Another sign is management goes quiet and provides only sec required communication to investors. Another sign is management starts removing people and open positions and board seats are not filled unless they have extensive M&A experience.

I think Cydy is getting acquired. Or at least one indication is. Partnerships with a company that only has one drug makes things muddled. Same drug with different partners for different indications would be very muddled due the off label, different time frames for approvals. CYDY is 772m in debt! The 350m shares even at 2 bucks won't cover the debt. But it does allow for a go it alone threat if not offered the price asked for. Also most 90%normal acquisitions/buyouts happen to non revenue and non approved drugs. Most small biotechs can't afford to run meaningful trials.

Looking at new members joining CYDY, Attorney company counsel Tyler Blok, President not CEO til after a 6 months trial Cyrus and Cunningham, board member Burke all new to Cydy all have extensive major M&A experience actually their specialty. And as usual my saying us being bought out is my opinion and speculation. And as I have all along maintained it will be ViiV and GSK with a possible outside chance buy out from Abbvie.

So my time line is only a guess. My thought is the buyout may happen before the added shares vote as if after the vote that just costs the acquiring company much more money to cover the shares.

1
Reply
Share
Report
Save
Follow

It would allow baby to sell just enough shares to set a market price, pay off a bit of debt and hand baby debt free to shareholders and it would all be legal. That is why the might do it. Look at gsk and haleon (hln) the spun consumer healthcare out of a pharmacy company. They directly gave shares in the new company to the stockholders of the old company. They then moved debt as around however the ceo and board liked. Assignment of debt should be logical and fair in corporate America. - it is not.

1
Reply
Share
Report
Save
Follow

20 year returns:

AAPL 66k % Msft 1k % Amazon 18k% TSLA (10year) 5k %

Ofc going forward the growth will be a small percentage of these, but still think they will outperform big cap healthcare companies (jnj, GSK,unh, etc)

1
Reply
Share
Report
Save
Follow

Long MCY, BABA, and GSK

1
Reply
Share
Report
Save
Follow

Sell short crap stocks trading near ATHs based on stupid media and WSB pumping. Buy value stocks trading near ATLs out of undue fear of some event. My portfolio is up 45% YTD. Just bought GSK. Previously bought puts on Ford, SPCE, Tesla when they were trading at ATHs.

1
Reply
Share
Report
Save
Follow

Just bought GSK. Seems like Zantac legal liability is fully baked into stock ($15bn dump in last 10 days). Trading near 13-year low. If this isn't value at a discount, I don't know what is.

1
Reply
Share
Report
Save
Follow

GSK

1
Reply
Share
Report
Save
Follow

GSK - their legal troubles are making it the stock an attractive entry point. They are a solid company already, plus you know, they just cured cancer so there’s that.

1
Reply
Share
Report
Save
Follow

In the Neogen, it is voluntary split-off.

But it doesn't always have to be - sometimes it could be a spin-off or demerger instead of a split-off.

For example - the recent GSK demerger of their health care business. In that situation - it is a mandatory corporate action, where shareholders of GSK received a share of Haleon.

The health care announcement said it was a spin-off. That implies you may get shares of the spin-off.

Short explanation here (not sure about accuracy though) - https://www.investopedia.com/articles/investing/090715/comparing-spinoffs-splitoffs-and-carveouts.asp

1
Reply
Share
Report
Save
Follow

23andMe. ME is their ticker. It's possible it never gets back to IPO price but I think the data alone is invaluable, just has never been valuated before so the markets don't know what to think about it. The work they're doing with GSK is very promising and they're just going to get more and more insight as they connect the dots. Eventually, I think we'll all be using it to see what meds we're most compatible with.

1
Reply
Share
Report
Save
Follow

is GSK viable buy atm? they r coming from a huge drop

1
Reply
Share
Report
Save
Follow

Gsk and sanofi calls all-in

1
Reply
Share
Report
Save
Follow

The market has already priced in a Purdue Pharma level of fuckery into the GSK valuation. To me this is a screaming buy. I'm buying.

1
Reply
Share
Report
Save
Follow

>*GSK: NO EVIDENCE OF ASSOCIATION BETWEEN RANITIDINE, CANCER $GSK

^*Walter ^Bloomberg ^@DeItaone ^at ^2022-08-11 ^15:40:38 ^EDT-0400

1
Reply
Share
Report
Save
Follow

Gsk dropped 10% today. Good buy?

1
Reply
Share
Report
Save
Follow

Haleon used to be part of GSK. Of course it will share certain responsibilities for the products made before the split.

1
Reply
Share
Report
Save
Follow

According to the article: "Haleon said it’s not a party of the litigation proceedings", but "it has certain indemnification obligations to GSK and Pfizer" so "analysts flagged Haleon’s involvement in Zantac litigation was limited."

I don't fully understand the "indemnification obligations to..." part, does that mean Haleon is liable to some claims, or GSK is liable to compensate Haleon in case Haleon is affected by the lawsuit? I only did BusLaw101 in uni and obviously it wasn't enough :)

1
Reply
Share
Report
Save
Follow

>*GSK DROPS AS MUCH AS 12%, BIGGEST FALL SINCE FEBRUARY 1998 $GSK

^*Walter ^Bloomberg ^@DeItaone ^at ^2022-08-11 ^07:33:19 ^EDT-0400

1
Reply
Share
Report
Save
Follow

Question… If the USD is strong now, should I buy something like GSK, SNY, or NVS that’s flat or down YTD? I am thinking that if the dollar drops in value versus the euro/pound, their target markets would produce a greater profit versus US drug manufacturers which would be forced to raise their prices to make the same as now or lose out to European competition that could offer similar products?

1
Reply
Share
Report
Save
Follow

I have some core holding that I will sell on a run up and by back on a dip. I will always hold - also I will hold more than 10% in one stock or fund. AaplSome of my core holding- Aapl abbv cost DUK so pfe and gsk

1
Reply
Share
Report
Save
Follow
  1. needs more data
  2. only applies to a tiny subset of a particular cancer.

They need to show it to work with longer follow up times and more patients...

So buying GSK now it's kinda having faith on the thing working in the future.

Might happen, might not.

A lot of these clinical trials are biased towards wanting the subjects that will look the best in results.

Like you don't want the 135 years old with five different cancers because it's way too complicated to assess whether your stuff works.

So there is that uncertainty too.

Biology is messy.

Position : i have like 5 SoFi shares...

1
Reply
Share
Report
Save
Follow

GSK cancer drug jemperli cures 100% of cancer patients tested in trial - stock is at 12 month low, this one confuses me https://www.mmm-online.com/home/channel/7-day-supply/a-cancer-drug-trial-produced-a-100-remission-rate-confirming-the-results-thats-another-story/

1
Reply
Share
Report
Save
Follow

It took a while but my Haleon shares finally arrived last week. My account is showing my original GSK cost basis went up and Haleon shares cost basis is 0.

1
Reply
Share
Report
Save
Follow

After GSK did the demerger, the went through a 4:5 reverse split. This means for every 5 shares of GSK you had became 4 shares at the same total cost basis. Being that you only had 1 share to start with, you should have ended up with 0.2 shares; but they may not have distributed fractional shares and instead given you cash value.

Edit: https://www.gsk.com/en-gb/investors/corporate-actions/consumer-healthcare-demerger/

1
Reply
Share
Report
Save
Follow

After GSK did the demerger, the went through a 4:5 reverse split. This means for every 5 shares of GSK you had became 4 shares at the same total cost basis. Being that you only had 1 share to start with, you should have ended up with 0.2 shares; but they may not have distributed fractional shares and instead given you cash value.

1
Reply
Share
Report
Save
Follow

Reminds me of my dividend payment from GSK of 0.01£ 💀

1
Reply
Share
Report
Save
Follow

This does not explain why GSK is delisted

1
Reply
Share
Report
Save
Follow

What I'm holding now isn't what I've always held. I have long term holds like Apple and Microsoft, and others I buy and sell.

This is off topic of the consolidation question, but I'm happy to answer questions. No, I first bought TSLA in this account, at $421 in 2020.

Here's just some of what I sold as part of rebalancing and consolidation in January 2022 for example, from my investing notes:

BITO
RBBN
ARKF
CRON
GO
AWAY
IPO
JETS
PRGTX
IMMR
LUMN
PEJ
ECOL
NERD
HERO
VTRS
SCJ
JIESX
LBNDX
EVIBX
FPE
USB
GSJY
PHM
JPN
BMY
AZN
STOR
UBA
RESE
O
GAMR
VIAC
XLF
SBUX
CSQ
ARCC
TGT
FUTY
JNJ
MPW
THQ
HAIL
QQQM
SYY
SCHA
SPG
VYM
GSK
NKE
PRBLX
KR
NRG
VOOV
SLYG
ALK
XLB
JBLU
DGRO
SCHW
SCHD
BERY
TM
JPM
SNY
SAR
C
PLD
STWD
IJR
VBR
ABBV
PFE
WFC
BAC
CVS
ACI
BNTX
FB
AY
CNRG
IDRV
NEP

1
Reply
Share
Report
Save
Follow

Why is my broker charging me for GSK demerger?

1
Reply
Share
Report
Save
Follow

Anybody know what the share price for GSK was at time of the split? I need this for my quicken account and I can’t seem to locate it anywhere.

1
Reply
Share
Report
Save
Follow

GSK spun off the "oral products" (like toothpaste, pills etc) as HALEON. I believe you get 1 free share of HLN for every GSK share you own. Then GSK also reverse-split, so every 5 GSK shares becomes 4 GSK shares. You should check your total number of GSK shares, there might be some shady moves to round-down odd shares.

1
Reply
Share
Report
Save
Follow

I finally received my new Haleon shares today.

Remember though- it’s a European stock and if you look at the fine print, each share of GSK you buy on the NYSE is equal to two GSK, so I received two HLN.L for each GSK I owned. Yay!

However, my GSK is still missing it is frozen in limbo - still waiting for the GSK to drop into my account

1
Reply
Share
Report
Save
Follow

I received shares of Haleon today equal to the number of shares I own of GSK

1
Reply
Share
Report
Save
Follow

Im glad you're talking about it, I have GSK and woke up to shares in Haleon I wasn't sure why but I assumed they were connected

1
Reply
Share
Report
Save
Follow

Link to demerger circular here - https://www.gsk.com/media/9253/gsk-plc-circular.pdf

See page 94 to 96.

1
Reply
Share
Report
Save
Follow

Here you go:

The GSK Share Consolidation will not result in a change to the ratio of GSK shares represented by each GSK ADS. However, following the GSK Share Consolidation becoming effective, the existing GSK shares held by the ADS Depositary will be replaced with a smaller number of new GSK shares. As a result, GSK ADS holders will, upon cancellation of their existing GSK ADSs, be issued with and receive 4 new GSK ADSs for every 5 existing GSK ADSs.

It is expected that “regular-way” trading with respect to existing GSK ADSs will end at market open on Tuesday 19 July 2022 and that “regular-way” trading with respect to new GSK ADSs will commence on the New York Stock Exchange (the “NYSE”) at market open on Friday 22 July 2022. In addition, it is expected that new GSK ADSs will begin trading on a “when-issued” basis on the NYSE from market open on Tuesday 19 July 2022 and continue up to and including Thursday 21 July 2022. New GSK ADSs will trade under the CUSIP number 37733W204.

Further details on the impact of the GSK Share Consolidation on GSK ADS holders are provided in the Circular, which is available on GSK’s website at www.gsk.com/demerger.

https://www.gsk.com/en-gb/media/press-releases/completion-of-gsk-share-consolidation/

1
Reply
Share
Report
Save
Follow

Two thigs occurred:

  1. GSK had a demerger of its consumer healthcare business. So you should have received 1 share of Haleon (HLN) for every share of GSK.
  2. GSK also did a share consolidation (i.e. reverse split) where you received 4 new ordinary shares for every 5 existing ordinary shares. So your 8 shares became 6.4 shares at the same total cost basis.
1
Reply
Share
Report
Save
Follow

i dont really think about buyouts. it really is all-in on Yutrepia. i'm sure some other company in respiratory would love to add it to their salesforce. GSK, AZN, idk. they just need final approval/launch from this court.

1
Reply
Share
Report
Save
Follow

GSK cures cancer then de-lists?

1
Reply
Share
Report
Save
Follow

The demerger circular is here - https://www.gsk.com/media/7700/gsk-plc-circular.pdf

From the circular - tl;dr "If you are an ADS Holder, you will be entitled to receive:

one Haleon ADS for each GSK ADS you hold at the ADS Holder Record Time"

1
Reply
Share
Report
Save
Follow

I see a Haleon trading "when issued" basis, I'll guess will probably trade normally within a week or two but not certain on timeline. I'd contact GSK investor relations or go through the merger press releases to try to find more info. Not sure why your GSK shares would be gone - for that I'd ask Fidelity.

1
Reply
Share
Report
Save
Follow

How is the GSK demerger going to work in the US?

  • What I expected was to see 500 shares of Haleon suddenly appear in my account this morning, and to see the price of my GSK shares drop somewhat.

  • What I actually see is: my GSK shares have -disappeared completely-, and -nothing- to take their place.

Does this have anything to do with the fact that "GSK" in the US is just ADRs, and that perhaps Haleon doesn't have an ADR program set up yet, so "I own something I can't hold" at Fidelity??

1
Reply
Share
Report
Save
Follow

The market cap of Haleon is currently £27B (£30B at listing) making me wonder if GSK would not have been better off selling it to Unilever at the £50B offered. Well, I guess we'll see how things work out. Personally, I tend to stay away from old companies because of their complicated processes and structures making them inefficient.

1
Reply
Share
Report
Save
Follow

Wtfuck just happened to £GSK

1
Reply
Share
Report
Save
Follow

PG (owners of pepto) RKT ( owners of gaviscon) GSK (owner of tums) are the real brown chip stocks here

1
Reply
Share
Report
Save
Follow

Lots of great plays for tomorrow 🤘

New Microphone purchased and I will have plays for us tomorrow! Especially on GSK

1
Reply
Share
Report
Save
Follow

She has a red blister on her lip line.

$GSK is going to be up #valtrex

1
Reply
Share
Report
Save
Follow

All shares:

SHOP COF ABNB AMD GSK GOOG AXSM JOBY TQQQ UBER DIS

1
Reply
Share
Report
Save
Follow

GSK to 50 within a month.

1
Reply
Share
Report
Save
Follow

Ok. Kind of like what I’m doing. Two positions I have are Gsk puts $43 for Aug and Su calls 41 fo sept.

Good luck

1
Reply
Share
Report
Save
Follow

SAP, Volkswagen, GSK, KBC, ABI.

1
Reply
Share
Report
Save
Follow

GSK

1
Reply
Share
Report
Save
Follow

Commodities are TANKING brother. P/E ratios, again don't matter because we haven't seen shitty earnings from stocks that aren't shitty (snap, datadog, whatever the fuck) when quality stocks like GSK, Merck, Kroger are posting record net income quarter after quarter. We're pricing in a negative 2nd quarter GDP out of fear and all the research I've done points to supply chains being repaired and either a 0.0% GDP, which would be bullish, or higher.

1
Reply
Share
Report
Save
Follow

Mostly just COVID becoming less of a critical issue. Biotech/pharma companies significantly involved in either testing or vaccine development/production seem to follow that trend of peaking around summer 2021, when demand was high (e.g. Moderna or Quidel). Companies more broadly diversified in this sector such as GSK or Merck haven't dropped anywhere near as much, actually both of those stocks increased over 10% last year, unlike most other stocks.

Even though Moderna may be making less and less profit from the COVID vaccines etc. (however booster vaccines may provide continued revenues) they have good fundamentals, low debt etc. and they've had the opportunity to test a relatively new but powerful type of therapeutic/vaccine (MRNA based). Potentially Moderna will be able to use this to develop something new.

There's ovbiously no guarantees, but I personally thought Moderna looks decent.

1
Reply
Share
Report
Save
Follow

About 30% overall. About 10% on my income/value account and over 30 on my tech/growth. I'm still up on KO, VICI, GSK and, most surprisingly...USOI (not really surprising, considering what it is,) but that's not a huge portion of my overall.

1
Reply
Share
Report
Save
Follow

My Apple 125 puts expiry on june24 so I took my loss on them.

Was close. At least my GSK puts are still printing. Hopefully cancels out my loss on those

1
Reply
Share
Report
Save
Follow

GSK - on Cancer cure

1
Reply
Share
Report
Save
Follow

https://www.tradingview.com/chart/GSK/T9IPeLzH-CURE-FOR-CANCER/

1
Reply
Share
Report
Save
Follow

#Ban Bet Lost

/u/Billyshakes1597 (0/2) made a bet that GSK would go to 50.0 when it was 44.25 and it did not, so they were banned for a week.

1
Reply
Share
Report
Save
Follow

The demerger circular is here - https://www.gsk.com/media/7700/gsk-plc-circular.pdf

From the circular - tl;dr "If you are an ADS Holder, you will be entitled to receive:
one Haleon ADS for each GSK ADS you hold at the ADS Holder Record Time"

1
Reply
Share
Report
Save
Follow

GlaxoSmithKline GSK is going to spin off the consumer health care part, Haleon. If I buy the GSK ADR on the NYSE, what happens when that spinoff happens? Do I end up with foreign shares in the spinoff company?

1
Reply
Share
Report
Save
Follow

GSK ADR price fuckery

1
Reply
Share
Report
Save
Follow

Well I bought $43 Gsk puts a month ago.

We’ll see how this plays out now.

1
Reply
Share
Report
Save
Follow

And GSK pays a nice dividend >4.5% even now. I'm a buyer.

1
Reply
Share
Report
Save
Follow

GSK trading range narrowing

1
Reply
Share
Report
Save
Follow

Fuck yeah... GSK keeping me afloat today 🤚😌✋

1
Reply
Share
Report
Save
Follow

Gsk looks good to me rn

1
Reply
Share
Report
Save
Follow

GSK actually cures ass cancer and y'all won't even hop in smh

1
Reply
Share
Report
Save
Follow

Fuck it, GSK

1
Reply
Share
Report
Save
Follow

GSK 🚀

1
Reply
Share
Report
Save
Follow

VYGVF, UUUU, GSK and TSP. Once we lose another 5-10% will start loading up on 3X leveraged funds.

1
Reply
Share
Report
Save
Follow

I like GSK $45 weeklies for next week. Currently trading at 0.40, I could see it breaking through to 46 or so. Just had a cancer trial with 12/12 patients achieving total remission. Pretty unheard of actually, even if the sample size is small and it's early stage.

1
Reply
Share
Report
Save
Follow

Yes GSK

2
Reply
Share
Report
Save
Follow

Gsk? IOVA? Anyone getting in on these??

1
Reply
Share
Report
Save
Follow

GSK love ape(<_>)

1
Reply
Share
Report
Save
Follow

Gsk

1
Reply
Share
Report
Save
Follow

GSK, They Just Found the Cure for Cancerimg

1
Reply
Share
Report
Save
Follow

$gsk just found the cure for cancer. Even anderson Cooper is talking about it. At 180k annually, it’s a medicine you can’t refuse.

1
Reply
Share
Report
Save
Follow

GSK? ANAB? Cure for cancer?

1
Reply
Share
Report
Save
Follow

GSK calls

1
Reply
Share
Report
Save
Follow

GSK is teaching me a lesson

1
Reply
Share
Report
Save
Follow
Recent Tweets
$GSK looking very oversold here
1
1
1
GSK plays the white knight, paying $66 million to rescue Spero's oral antibiotic after FDA rejection! It tied a $150 million milestone to the delivery of the phase 3 program! $GSK $SPRO #pharma #antibiotic #FDA https://t.co/lIPAusZ0Hy
0
0
1
$GSK 32C Exp:21-Oct-22 ↑↑ 🚀 Total(Day): $62,880 #UnusualActivity Sign-up free for beta ver.:https://t.co/WnUoHPObTm https://t.co/dDFJCQGpsT
0
0
0
🏆 TOP 10 TRENDING PROJECTS according to https://t.co/ySHD3YlpYN ✈️ $DGF 🥈 $STCK 🥉 $PRESALE 4️⃣ $LSWAP 5️⃣ $TITS 6️⃣ $ALF 7️⃣ $HYP 8️⃣ $GSK 9️⃣ $SWIPE 🔟 $MXB ▶️ Source: https://t.co/7X0Jhw2H1j ▶️ Join us for more gems: https://t.co/D1aT0RhPJL https://t.co/oz3AzgGmt7
17
2
9
$GSK GSK selects Burberry's Brown as its first female CFO https://t.co/XR1g4cuKKD
0
0
0
$GSK $AZN $MRK Three withdrawals in advanced ovarian cancer spell trouble for PARP class - https://t.co/9X5A3FOJKN
0
1
2
It's a penny stock... it's an IPO... it's a SPAC... it's a sh*tcoin..... it's..🤔 it's..😯 it's..😧 it's..😨 A big pharma..😰 with a PEx12..😱 Div. yield of 6.50% 🫣.. $1.6B per quarter..😵 it's.. $GSK 😵‍💫💀🤷‍♂️ https://t.co/2tZjss34XR
1
0
4
$UL Imagine if Jope overpaid 30B USD for Haleon former $GSK Goodbye https://t.co/gLxl2tIKuN
0
0
2
wow $GSK cfo will bring biotech experience from Burberry. bright future ahead
2
0
7
$GSK - a well known BigPharma pharmaceutical company trading at prices not seen since 2009. Dividend yield over 6%. Recently opened a position in commons. 😎https://t.co/3kyjStgbxZ
0
0
2
$GSK trading green in a bad market. Jim working his Jimbo-magic..😂
0
0
5
$NBIO Increasing 4.94 % $NVAX $GSK $RAD $PFE 📈🚀💸
0
6
4
$SPRO solid catalyst.66m upfront cash and licence agreement with $GSK
0
0
2
$GSK $SPRO - Spero stock soars 79% as GSK to pick stake under license deal for UTI antibiotic https://t.co/qafC2bfs81
0
0
1
Cramer on $GSK: “I mean the spin-off's awful, they did a terrible job, the company is ill-advised." Come on baby work your magic😂
0
0
4
Haleon $HLN believes it is not liable for any potential Zantac liabilities " $GSK days it does not agree with Haleon's position" LOL https://t.co/RdGn0AngyF
2
1
5